$2.2 million follow-up grant from PATH to support new tools for polio eradication era

Today, Batavia Biosciences announces it received a follow-up grant of $2.2 million from PATH – a global organization dedicated to health equity – to develop and manufacture novel oral poliovirus vaccines (nOPV). 

Read more in bataviabiosciences.com

Leave a Reply

Your email address will not be published. Required fields are marked *